Vivek Das: How Obesity, Type 2 Diabetes, and Dyslipidaemia Interact Across Multiple Cardiovascular Conditions
Vivek Das, Lead Data Scientist at Novo Nordisk, shared a post on LinkedIn about a recent article by Paul C Evans, published in European Heart Journal, adding:
“A noticeable shift in cardiometabolic research is the move from isolated risk factors toward a more integrated, mechanism – driven view of disease.
Recent work highlights how obesity, type 2 diabetes, and dyslipidaemia interact across multiple cardiovascular conditions, rather than acting independently.
As biology becomes more interconnected, it reshapes how patients are stratified, how endpoints are defined, and how evidence is generated across the lifecycle.
For complex chronic diseases, the challenge is no longer identifying signals, but translating interconnected biology into coherent evidence that can inform decisions at scale.”
Title: Novel cardiovascular metabolic risk factor mechanisms and therapeutic opportunities: A scientific statement of the ESC Council on Basic Cardiovascular Science, the ESC Working Group on Atherosclerosis and Vascular Biology, the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Myocardial Function, and the ESC Working Group on Cardiac Cellular Electrophysiology
Authors: Paul C Evans, Gemma Vilahur, Petra Kleinbongard, Elena Osto, Carol Ann Remme, Rosalinda Madonna, Dunja Aksentijevic, Harald Sourij, Sean M Davidson, Donato Santovito, Jürgen Gindlhuber, Christian Weber, Wolfgang A Linke, Esther Lutgens, Luc Bertrand, Dana Dawson, Magnus Bäck, G Danilo Norata, Johann Wojta, Cinzia Perrino
Read the Full Article on European Heart Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 21, 2026, 21:58Toby Richards: WEHI Trial Solidifies IV Iron as Third-Trimester Standard
-
Aug 21, 2026, 21:51Mehak Trehan: From Reading the Chapter to Writing One
-
Aug 21, 2026, 21:38Ann Reilly: Navigating Postoperative vs. Acute Blood Loss Anemia – A CDI Case Study
-
Aug 21, 2026, 21:29Merlin Crossley: Atomic Precision in Sickle Cell Care – Structural Targeting for Fetal Globin Reactivation
-
Aug 21, 2026, 19:09Aphisit Thongthaisin: Admitted to Sorbonne University’s T2H University Diploma for 2026/2027
-
Aug 21, 2026, 19:07José Luis Ferreiro Gutiérrez: Proud to Be Elected Chairperson-Elect of the ESC Working Group on Thrombosis
-
Aug 21, 2026, 19:00Manuel Monreal: New RIETE Registry Data on VTE Recurrence and Bleeding During Anticoagulation
-
Aug 21, 2026, 18:39Ronak H. Mistry: Updated ASH ITP Guidelines Bring New Guidance for Managing ITP
-
Aug 21, 2026, 18:22Ahmed Bennis: NOAC Use Is Associated With Slower Cognitive Decline in AF and Alzheimer’s Disease